AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) Vaccine National Protocol
This protocol is for the supply and administration of AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) to individuals in accordance with the national COVID-19 vaccination programme.
3. Change history
Version number: V01.00
Change details: New protocol for AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) vaccine.
Date: 21 January 2021
Version number: V02.00
Change details: Updated protocol to reflect Armed Services staff roles
Date: 02 February 2021
Version number: V02.1
Change details: Clinical annex updated
Date: 22 February 2021
Contact
There is a problem
Thanks for your feedback